SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 30.60-2.3%11:16 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Douglas who wrote (112)4/15/1997 9:56:00 PM
From: Gerald Thomas   of 455
 
You have to click "view images" on top of page...

I don't know what you saw but there are 14 pages of controlled experiments ..I even saw comparisons to ddi and azt...
all charts appeared to show 100% blockage of infection in varing dosages and time periods..Upon reflection it was filed 2 weeks ago but most of it appeared to be In Vitro..
But the quantity of info I saw was unbelieveable and I have now changed my oppinion on this stock..
Initially there In Vitro claims didn't mean anything to me ...
But the quantity and quality of info I saw has dramatically changed my mind even though in laboratory conditions...
I had no idea the amount of different quantitative and differing protocols that were attempted by procept and numerous conclusions about specific amounts of binding etc.
The most I have ever seen from the company was 1 paragraph
saying in vitro was successful...I had no idea the degree and scope of the information.......

This is my oppinion but what I saw would be PLENTY to hand to NIH or anyone else to convince them pro-2000 works...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext